Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy

Christoph Beglinger; Jean Dudler; Christian Mottet; Laurent Nicod; Frank Seibold; Peter M. Villiger; Jean-Pierre Zellweger

doi:10.4414/smw.2007.11939

Peer reviewed clinical letter

Vol. 137 No. 4344 (2007)

Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy

Christoph Beglinger
Jean Dudler
Christian Mottet
Laurent Nicod
Frank Seibold
Peter M. Villiger
Jean-Pierre Zellweger

Fulltext PDF

DOI: https://doi.org/10.4414/smw.2007.11939
Cite this as:: Swiss Med Wkly. 2007;137:620-622
Published: 03.11.2007

How to Cite

1.

Beglinger C, Dudler J, Mottet C, Nicod L, Seibold F, M. Villiger P, Zellweger J-P. Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy. Swiss Med Wkly [Internet]. 2007 Nov. 3 [cited 2024 Nov. 21];137(4344):620-2. Available from: https://smw.ch/index.php/smw/article/view/788

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Andrea Kreienbuehl, Gerhard Rogler, Burri Emanuel, Luc Biedermann, Christian Meier, Pascal Juillerat, Sophie Restellini, Peter Hruz, Stefan R. Vavricka, Daniel Aeberli, Frank Seibold, Bone health in patients with inflammatory bowel disease , Swiss Medical Weekly: Vol. 154 No. 6 (2024)
Laura Rossier, Christoph Matter, Emanuel Burri, Tatiana Galperine, Petr Hrúz, Pascal Juillerat, Alain Schoepfer, Stephan R. Vavricka, Nadine Zahnd, Natalie Décosterd, Frank Seibold, Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice , Swiss Medical Weekly: Vol. 153 No. 8 (2023)
Emanuel Burri, Christoph Beglinger, Faecal calprotectin – a useful tool in the management of inflammatory bowel disease , Swiss Medical Weekly: Vol. 142 No. 1314 (2012)
Carlo Balmelli, Frédéric Zysset, Alberto Pagnamenta, Patrick Francioli, Catherine Lazor-Blanchet, Giorgio Zanetti, Jean-Pierre Zellweger, Contact tracing investigation after professional exposure to tuberculosis in a Swiss hospital using both tuberculin skin test and IGRA , Swiss Medical Weekly: Vol. 144 No. 3334 (2014)
Emanuel Burri, Pascal Juillerat, Michel H. Maillard, Michael Manz, Pierre Michetti, Christian Mottet, Gerhard Rogler, Nadine Zahnd, Stephan Vavricka, Position statement on the use of biosimilars in inflammatory bowel disease , Swiss Medical Weekly: Vol. 149 No. 4950 (2019)
Christian Auer, Sabine Kiefer, Meike Zuske, Christian Schindler, Kaspar Wyss, Johannes Blum, Xavier Bosch-Capblanch, Ursula Widmer, Sonia Sauthier, Jean-Paul Janssens, Katharina Bossard, Christophe Chatonnet, Jesica Mazza-Stalder, Bea Zacek, Jean-Pierre Zellweger, Ekkehardt Altpeter, Mirjam Mäusezahl, Health-seeking behaviour and treatment delay in patients with pulmonary tuberculosis in Switzerland: some slip through the net , Swiss Medical Weekly: Vol. 148 No. 3536 (2018)
Federico Balagué, Valérie Piguet, Jean Dudler, Steroids for LBP – from rationale to inconvenient truth , Swiss Medical Weekly: Vol. 142 No. 1516 (2012)
Apostolos Sarivalasis, Patrick Bodenmann, Elisabeth Langenskiold, Caroline Lutchmaya- Flick, Oscar Daher, Jean-Pierre Zellweger, High rate of completion of preventive therapy for latent tuberculosis infection among asylum seekers in a Swiss Canton , Swiss Medical Weekly: Vol. 143 No. 3536 (2013)
Peter Helbling, Ekkehardt Altpeter, Jean-Marie Egger, Jean-Pierre Zellweger, Treatment outcomes of multidrug-resistant tuberculosis in Switzerland , Swiss Medical Weekly: Vol. 144 No. 4950 (2014)
Christoph Beglinger, Inflammatory bowel disease , Swiss Medical Weekly: Vol. 139 No. 3738 (2009)

1 2 > >>